What could genomic medicine do in the future?
DNA gel image via www.shutterstock.com.
Although genomics research has the potential to revolutionize medicine, it has limitations. It may not do much to prevent many of the leading causes of death.
Blood is drawn from an unidentified patient during a routine exam Thursday, Dec. 8, 2016 at a Boston area medical clinic.
AP Photo/Dwayne Desaulniers
New regulations for research with human blood and tissue try to balance scientific progress with patient privacy.
President Barack Obama signs the 21st Century Cures Act on Tuesday, Dec. 13, 2016, in Washington.
Kevin Wolf/AP Images for Parker Foundation
Lowering the threshold for FDA approval and feeding the agency less rigorous information will increase the likelihood of approvals of unsafe or ineffective drugs and devices.
Obama annually welcomed students to the White House with their Science Fair projects.
AP Photo/Susan Walsh
The outgoing president leaves behind some solid accomplishments in the world of science, tech and medicine. But the biggest departure from his predecessors might have been in his approach.
A mother holds the foot of her premature baby. Prematurity is the most common cause of neonatal death globally.
In developed countries, the main causes of preterm deaths are well known and studied.But in low resource countries, the causes are much less understood.
Precision public health can make a huge difference to people across Africa.
Albert González Farran, UNAMID
Precision public health has the potential to transform the global health sphere by ensuring that the right interventions are brought to the right people in the right places.
DNA image via www.shutterstock.com.
We should heed concerns about how private genetic data banks are used and accessed before we enable a system where the future of public genetic research lies in private hands.
Would you donate to a biobank?
How much privacy are we willing to give up in the name of cutting-edge science? And do we care about the kinds of research that will be done with our donations?
Our knowledge of diseases is growing exponentially, but turning knowledge into cures is proving to be a tricky business.
Why we must work out why some people respond exceptionally well to cancer treatments.
Phil and Pam Gradwell (to be)/Flickr
Some patients respond miraculously well to cancer treatment. It is high time we try to understand why.
Genomes don’t translate easily into an understanding of disease.
Big data is all well and good, but if we want medical breakthroughs, we'll need big theory too.
Who’s in charge once your biological material is out of your body?
Next-generation genomic research depends on study participants sharing their biological materials with scientists. But concerns over how that information is protected may hold some people back.
Effects may vary.
Why does the same medication, at the same dose, work well for some people, but not for others? The answer is in our genes.
Understanding the DNA of tumours allows researchers to target treatment to each individual.
Personalised medicine is based on the idea that by understanding the specific molecular code of a person’s disease, and particularly its genetic makeup, we can more accurately tailor treatment.
Where do you live?
Understanding genetics isn't enough to solve our health problems – we need to look at where people live, too.
BRCA1 and BRCA2 gene mutations prompted Angelina Jolie to have a preventative double mastectomy and surgery to remove both ovaries.
What if you could take a simple test to reveal your individual risk of developing a range of cancers and hundreds of other diseases?
Precision medicine delivers treatment based on the particular variant of the disease by taking the genetic make-up of the ill person into account.
Hidden among all the other announcements in last week’s State of the Union address by US President Barack Obama was a promise to fund a new “precision medicine initiative”. The president said it would…